Susan G. Komen® Unveils $26 Million Investment in Research Funding Focused on Metastatic Breast Cancer and New Treatments
Susan G. Komen®, the world’s leading breast cancer organization, today announced $26 million in funding for new research projects that focus on metastatic breast cancer, developing new, more-effective treatments, and addressing disparities in breast cancer…